Is Placebo Response Responsible for Many Phase III Failures?
Clin Pharmacol Ther
.
2019 Dec;106(6):1151-1154.
doi: 10.1002/cpt.1632.
Authors
Teodora Pene Dumitrescu
1
,
Jeanine McCune
2
,
Virginia Schmith
3
Affiliations
1
Clinical Pharmacology Modeling and Simulation, GlaxoSmithKline, Durham, North Carolina, USA.
2
Department of Population Sciences, Beckman Research Institute/City of Hope, Duarte, California, USA.
3
Nuventra Pharma Sciences, Cocoa Beach, Florida, USA.
PMID:
31713241
DOI:
10.1002/cpt.1632
No abstract available
Publication types
Editorial
Introductory Journal Article
MeSH terms
Clinical Trials, Phase III as Topic*
Drugs, Investigational / therapeutic use*
Humans
Placebo Effect*
Research Design*
Treatment Failure
Substances
Drugs, Investigational